Skip to main content
Top
Published in: Indian Journal of Surgery 4/2017

01-08-2017 | Editorial

Indian Solutions for Indian Problems—Association of Breast Surgeons of India (ABSI) Practical Consensus Statement, Recommendations, and Guidelines for the Treatment of Breast Cancer in India

Authors: S. P. Somashekhar, Gaurav Agarwal, S. V. S. Deo, Chintamani, P. Raghu Ram, Diptendra Sarkar, Vani Parmar

Published in: Indian Journal of Surgery | Issue 4/2017

Login to get access

Excerpt

Breast cancer is considered as the most common type of female cancer accountable for nearly 23% of all cancers in women globally [1, 2]. It is believed that global prevalence of breast cancer will cross two million by the year 2030 which will have the major contributors from developing countries [3]. As far as India is concerned, the incidence rates vary across the country with northeast and metropolitan cities (Mumbai, New Delhi) showing the highest rates [4]. The factors which contribute to this variation include demographic differences (education), lifestyle factors (use of tobacco and alcohol), anthropometric factors (adiposity), and reproductive factors (age at first child and number of children) [4]. One of the most common contributors to the high mortality rate is due to the diagnosis at advance stages of the disease which can be due to low awareness, incomplete treatment regimens, and limited access to effective treatment at regional cancer centers [510]. As per National Breast Cancer Foundation, currently available treatments for breast cancer are based on a number of factors including size of tumor in relation to size of breast, result of specific pathology tests (hormone receptors, HER2 receptors), menopause, age, general health conditions, family history, or other risk factors [11]. The treatments include surgery, chemotherapy, radiation therapy, hormone therapy, and targeted therapy along with the involvement of nutrition and physical activity and follow-up care. …
Literature
1.
go back to reference Ferlay J, Soerjomataram I, Ervik M, Dikshit R, Eser S, Mathers C, et al (2012) Estimated cancer incidence, mortality and prevalance worldwide in 2012..v1.0 (IARC CancerBase No. 11) Ferlay J, Soerjomataram I, Ervik M, Dikshit R, Eser S, Mathers C, et al (2012) Estimated cancer incidence, mortality and prevalance worldwide in 2012..v1.0 (IARC CancerBase No. 11)
2.
go back to reference Global Burden of Disease Cancer Collaboration (2013) The globalburden of cancer. JAMA Oncol 2015 Global Burden of Disease Cancer Collaboration (2013) The globalburden of cancer. JAMA Oncol 2015
3.
go back to reference Jemal A, Bray F, Melissa MC, Jacques F, Elizabeth W, Forman D (2011) Global cancer statistics. CA Cancer J Clin 61:69–90CrossRefPubMed Jemal A, Bray F, Melissa MC, Jacques F, Elizabeth W, Forman D (2011) Global cancer statistics. CA Cancer J Clin 61:69–90CrossRefPubMed
4.
go back to reference National Cancer Registry Programme (2013) National Centre for Disease Informatics and Research and Indian Council of Medical Research, three year report of population based cancer registries 2009–2011 National Cancer Registry programme. National Cancer Registry National Cancer Registry Programme (2013) National Centre for Disease Informatics and Research and Indian Council of Medical Research, three year report of population based cancer registries 2009–2011 National Cancer Registry programme. National Cancer Registry
5.
go back to reference Sharma K, Costas A, Shulman LN, Meara JG (2012) A systematic review of barriers to breast cancer care in developing countries resulting in delayed patient presentation. J Oncol 2012:8CrossRef Sharma K, Costas A, Shulman LN, Meara JG (2012) A systematic review of barriers to breast cancer care in developing countries resulting in delayed patient presentation. J Oncol 2012:8CrossRef
6.
go back to reference Jones S, Johnson K (2012) Women’s awareness of cancer symptoms: a review of the literature. Women’s Health 8(5):579–591CrossRefPubMed Jones S, Johnson K (2012) Women’s awareness of cancer symptoms: a review of the literature. Women’s Health 8(5):579–591CrossRefPubMed
7.
go back to reference Jones C, Maben J, Jack RH, Davies EA, Forbes LJL, Lucas GR, et al (2014) A systematic review of barriers to early presentation and diagnosis with breast cancer among black women. BMJ Open;4(2). Jones C, Maben J, Jack RH, Davies EA, Forbes LJL, Lucas GR, et al (2014) A systematic review of barriers to early presentation and diagnosis with breast cancer among black women. BMJ Open;4(2).
8.
9.
go back to reference Pati S, Hussain MA, Chauhan AS, Mallick D, Nayak S (2013) Patient navigation pathway and barriers to treatment seeking in cancer in India: a qualitative inquiry. Cancer Epidemiol 37(6):973–978CrossRefPubMed Pati S, Hussain MA, Chauhan AS, Mallick D, Nayak S (2013) Patient navigation pathway and barriers to treatment seeking in cancer in India: a qualitative inquiry. Cancer Epidemiol 37(6):973–978CrossRefPubMed
10.
go back to reference Torre L, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, Jemal A (2015) Global cancer statistics, 2012. CA Cancer J Clin 65(2):87–108CrossRefPubMed Torre L, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, Jemal A (2015) Global cancer statistics, 2012. CA Cancer J Clin 65(2):87–108CrossRefPubMed
15.
go back to reference Chauhan A, Sharma MM (2016) Evaluation of surgical outcomes following oncoplastic breast surgery in early breast cancer and comparison with conventional breast conservation surgery. Med J Armed Forces India 72(1):12–18CrossRefPubMed Chauhan A, Sharma MM (2016) Evaluation of surgical outcomes following oncoplastic breast surgery in early breast cancer and comparison with conventional breast conservation surgery. Med J Armed Forces India 72(1):12–18CrossRefPubMed
16.
go back to reference Tryfonidis K, Senkus E, Cardoso MJ et al (2015) Management of locally advanced breast cancer-perspectives and future directions. Nat Rev Clin Oncol 12(3):147–162CrossRefPubMed Tryfonidis K, Senkus E, Cardoso MJ et al (2015) Management of locally advanced breast cancer-perspectives and future directions. Nat Rev Clin Oncol 12(3):147–162CrossRefPubMed
18.
go back to reference Rolph R, Mehta S, Farhadi J (2016) Breast reconstruction: options post-mastectomy. Br J Hosp Med (Lond) 77(6):334–342CrossRef Rolph R, Mehta S, Farhadi J (2016) Breast reconstruction: options post-mastectomy. Br J Hosp Med (Lond) 77(6):334–342CrossRef
19.
go back to reference Guillem JG, Wood WC, Moley JF et al (2006) ASCO/SSO review of current role of risk-reducing surgery in common hereditary cancer syndromes. J Clin Oncol 24(28):4642–4660CrossRefPubMed Guillem JG, Wood WC, Moley JF et al (2006) ASCO/SSO review of current role of risk-reducing surgery in common hereditary cancer syndromes. J Clin Oncol 24(28):4642–4660CrossRefPubMed
20.
go back to reference Hartmann LC, Schaid DJ, Woods JE et al (1999) Efficacy of bilateral prophylactic mastectomy in women with a family history of breast cancer. N Engl J Med 340(2):77–84CrossRefPubMed Hartmann LC, Schaid DJ, Woods JE et al (1999) Efficacy of bilateral prophylactic mastectomy in women with a family history of breast cancer. N Engl J Med 340(2):77–84CrossRefPubMed
21.
go back to reference Domchek SM, Friebel TM, Singer CF et al (2010) Association of risk-reducing surgery in BRCA1 or BRCA2 mutation carriers with cancer risk and mortality. JAMA 304(9):967–975CrossRefPubMedPubMedCentral Domchek SM, Friebel TM, Singer CF et al (2010) Association of risk-reducing surgery in BRCA1 or BRCA2 mutation carriers with cancer risk and mortality. JAMA 304(9):967–975CrossRefPubMedPubMedCentral
22.
go back to reference Rebbeck TR, Friebel T, Lynch HT et al (2004) Bilateral prophylactic mastectomy reduces breast cancer risk in BRCA1 and BRCA2 mutation carriers: the PROSE Study Group. J Clin Oncol 22(6):1055–1062CrossRefPubMed Rebbeck TR, Friebel T, Lynch HT et al (2004) Bilateral prophylactic mastectomy reduces breast cancer risk in BRCA1 and BRCA2 mutation carriers: the PROSE Study Group. J Clin Oncol 22(6):1055–1062CrossRefPubMed
23.
go back to reference Meijers-Heijboer H, van Geel B, van Putten WL et al (2001) Breast cancer after prophylactic bilateral mastectomy in women with a BRCA1 or BRCA2 mutation. N Engl J Med 345(3):159–164CrossRefPubMed Meijers-Heijboer H, van Geel B, van Putten WL et al (2001) Breast cancer after prophylactic bilateral mastectomy in women with a BRCA1 or BRCA2 mutation. N Engl J Med 345(3):159–164CrossRefPubMed
24.
go back to reference Peto R, Boreham J, Clarke M et al (2000) UK and USA breast cancer deaths down 25% in year 2000 at ages 20–69 years [letter]. Lancet 355:1822CrossRefPubMed Peto R, Boreham J, Clarke M et al (2000) UK and USA breast cancer deaths down 25% in year 2000 at ages 20–69 years [letter]. Lancet 355:1822CrossRefPubMed
25.
go back to reference Early Breast Cancer Trialists' Collaborative Group (1998) Tamoxifen for early breast cancer: an overview of the randomized trials. Lancet 351:1451–1467CrossRef Early Breast Cancer Trialists' Collaborative Group (1998) Tamoxifen for early breast cancer: an overview of the randomized trials. Lancet 351:1451–1467CrossRef
26.
go back to reference Fisher B, Costantino JP, Wickerham DL et al (1998) Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study. J Natl Cancer Inst 90:1371–1388CrossRefPubMed Fisher B, Costantino JP, Wickerham DL et al (1998) Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study. J Natl Cancer Inst 90:1371–1388CrossRefPubMed
28.
go back to reference Sariego J (2010) Breast cancer in the young patient. Am Surg 76(12):1397–1400PubMed Sariego J (2010) Breast cancer in the young patient. Am Surg 76(12):1397–1400PubMed
29.
go back to reference Sariego J, Zrada S, Byrd M et al (1995) Breast cancer in young patients. Am J Surg 170(3):243–245CrossRefPubMed Sariego J, Zrada S, Byrd M et al (1995) Breast cancer in young patients. Am J Surg 170(3):243–245CrossRefPubMed
Metadata
Title
Indian Solutions for Indian Problems—Association of Breast Surgeons of India (ABSI) Practical Consensus Statement, Recommendations, and Guidelines for the Treatment of Breast Cancer in India
Authors
S. P. Somashekhar
Gaurav Agarwal
S. V. S. Deo
Chintamani
P. Raghu Ram
Diptendra Sarkar
Vani Parmar
Publication date
01-08-2017
Publisher
Springer India
Published in
Indian Journal of Surgery / Issue 4/2017
Print ISSN: 0972-2068
Electronic ISSN: 0973-9793
DOI
https://doi.org/10.1007/s12262-017-1666-3

Other articles of this Issue 4/2017

Indian Journal of Surgery 4/2017 Go to the issue